Intelligent bio solutions inc. announces pricing of $2.6 million public offering of common stock

New york, feb. 20, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of its previously announced underwritten public offering of 1,304,348 shares of common stock at a public offering price of $2.00 per share of common stock, for gross proceeds of approximately $2.6 million, before deducting underwriting discounts and commissions and offering expenses.
INBS Ratings Summary
INBS Quant Ranking